BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grubor V, Krasnitz A, Troge JE, Meth JL, Lakshmi B, Kendall JT, Yamrom B, Alex G, Pai D, Navin N. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Blood. 2009;113:1294-1303. [PMID: 18922857 DOI: 10.1182/blood-2008-05-158865] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Chiorazzi N. Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology 2012;2012:76-87. [DOI: 10.1182/asheducation.v2012.1.76.3806845] [Cited by in Crossref: 39] [Article Influence: 3.9] [Reference Citation Analysis]
2 Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. J Mol Diagn 2013;15:196-209. [PMID: 23273604 DOI: 10.1016/j.jmoldx.2012.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
3 Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, Hamoudi R, Liu H, Dong G, Attygalle A, McPhail ED, Law ME, Isaacson PG, de Leval L, Wotherspoon A, Du MQ. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J Pathol 2010;220:461-74. [PMID: 20077527 DOI: 10.1002/path.2665] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
4 Nadeu F, Delgado J, Royo C, Baumann T, Stankovic T, Pinyol M, Jares P, Navarro A, Martín-García D, Beà S, Salaverria I, Oldreive C, Aymerich M, Suárez-Cisneros H, Rozman M, Villamor N, Colomer D, López-Guillermo A, González M, Alcoceba M, Terol MJ, Colado E, Puente XS, López-Otín C, Enjuanes A, Campo E. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. Blood 2016;127:2122-30. [PMID: 26837699 DOI: 10.1182/blood-2015-07-659144] [Cited by in Crossref: 158] [Cited by in F6Publishing: 149] [Article Influence: 26.3] [Reference Citation Analysis]
5 Stevens-Kroef M, Simons A, Gorissen H, Feuth T, Weghuis DO, Buijs A, Raymakers R, Geurts van Kessel A. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification. Cancer Genet Cytogenet 2009;195:97-104. [PMID: 19963108 DOI: 10.1016/j.cancergencyto.2009.06.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
6 Viswanatha DS, Montgomery KD, Foucar K. Mature B-Cell Neoplasms. Hematopathology. Elsevier; 2011. pp. 221-46. [DOI: 10.1016/b978-0-7216-0040-6.00014-9] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Brown JR, Hanna M, Tesar B, Werner L, Pochet N, Asara JM, Wang YE, Dal Cin P, Fernandes SM, Thompson C, Macconaill L, Wu CJ, Van de Peer Y, Correll M, Regev A, Neuberg D, Freedman AS. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res 2012;18:3791-802. [PMID: 22623730 DOI: 10.1158/1078-0432.CCR-11-2342] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
8 Cavazzini F, Ciccone M, Negrini M, Rigolin GM, Cuneo A. Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia. Expert Rev Hematol 2009;2:305-14. [PMID: 21082972 DOI: 10.1586/ehm.09.22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Rodríguez A, Robledo C, García J, González M, Gutiérrez N, Hernández J, Sandoval V, García de Coca A, Recio I, Risueño A, Martín-núñez G, García E, Fisac R, Conde J, de las Rivas J, Hernández J. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling. Annals of Oncology 2012;23:2138-46. [DOI: 10.1093/annonc/mdr579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
10 Warburton D, Ronemus M, Kline J, Jobanputra V, Williams I, Anyane-Yeboa K, Chung W, Yu L, Wong N, Awad D, Yu CY, Leotta A, Kendall J, Yamrom B, Lee YH, Wigler M, Levy D. The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet 2014;133:11-27. [PMID: 23979609 DOI: 10.1007/s00439-013-1353-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 9.1] [Reference Citation Analysis]
11 Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foá R, Pasqualucci L, Rabadan R, Dalla-Favera R, Gaidano G. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011;208:1389-401. [PMID: 21670202 DOI: 10.1084/jem.20110921] [Cited by in Crossref: 428] [Cited by in F6Publishing: 396] [Article Influence: 38.9] [Reference Citation Analysis]
12 Landau DA, Wu CJ. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics. Genome Med 2013;5:47. [PMID: 23731665 DOI: 10.1186/gm451] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
13 Sutton L, Rosenquist R. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia. Seminars in Cancer Biology 2015;34:22-35. [DOI: 10.1016/j.semcancer.2015.04.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
14 Bertilaccio MT, Scielzo C, Muzio M, Caligaris-Cappio F. An overview of chronic lymphocytic leukaemia biology. Best Pract Res Clin Haematol 2010;23:21-32. [PMID: 20620968 DOI: 10.1016/j.beha.2009.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
15 Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, Marks S, Lakshmi B, Pai D, Ye K, Buja A, Krieger A, Yoon S, Troge J, Rodgers L, Iossifov I, Wigler M. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011;70:886-97. [PMID: 21658582 DOI: 10.1016/j.neuron.2011.05.015] [Cited by in Crossref: 484] [Cited by in F6Publishing: 433] [Article Influence: 44.0] [Reference Citation Analysis]
16 Lee YH, Ronemus M, Kendall J, Lakshmi B, Leotta A, Levy D, Esposito D, Grubor V, Ye K, Wigler M, Yamrom B. Reducing system noise in copy number data using principal components of self-self hybridizations. Proc Natl Acad Sci U S A 2012;109:E103-10. [PMID: 22207624 DOI: 10.1073/pnas.1106233109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
17 Schnaiter A, Mertens D, Stilgenbauer S. Genetics of Chronic Lymphocytic Leukemia. Clinics in Laboratory Medicine 2011;31:649-58. [DOI: 10.1016/j.cll.2011.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Coll-mulet L, Gil J. Genetic alterations in chronic lymphocytic leukaemia. Clin Transl Oncol 2009;11:194-8. [DOI: 10.1007/s12094-009-0340-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
19 Rodríguez-vicente AE, Díaz MG, Hernández-rivas JM. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease. Cancer Genetics 2013;206:49-62. [DOI: 10.1016/j.cancergen.2013.01.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
20 Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang C, Zhang W, Wan J. Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression. Med Oncol 2011;28:1017-22. [PMID: 20585902 DOI: 10.1007/s12032-010-9602-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
21 Wu CJ. CLL clonal heterogeneity: an ecology of competing subpopulations. Blood 2012;120:4117-8. [PMID: 23160186 DOI: 10.1182/blood-2012-09-452805] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
22 Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013;152:714-26. [PMID: 23415222 DOI: 10.1016/j.cell.2013.01.019] [Cited by in Crossref: 934] [Cited by in F6Publishing: 864] [Article Influence: 103.8] [Reference Citation Analysis]
23 Kolquist KA, Schultz RA, Slovak ML, McDaniel LD, Brown TC, Tubbs RR, Cook JR, Theil KS, Cawich V, Valentin C, Minier S, Neill NJ, Byerly S, Morton SA, Sahoo T, Ballif BC, Shaffer LG. Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis. Mol Cytogenet 2011;4:25. [PMID: 22087757 DOI: 10.1186/1755-8166-4-25] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
24 Delgado J, Villamor N, López-Guillermo A, Campo E. Genetic evolution in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol 2016;29:67-78. [PMID: 27742073 DOI: 10.1016/j.beha.2016.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Tang Z, Kanagal-Shamanna R, Tang G, Patel K, Medeiros LJ, Toruner GA. Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia. Leuk Res 2021;108:106616. [PMID: 34022744 DOI: 10.1016/j.leukres.2021.106616] [Reference Citation Analysis]
26 Ouillette P, Malek S. Acquired Genomic Copy Number Aberrations in CLL. In: Malek S, editor. Advances in Chronic Lymphocytic Leukemia. New York: Springer; 2013. pp. 47-86. [DOI: 10.1007/978-1-4614-8051-8_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
27 Caba O, Prados J, Ortiz R, Jiménez-Luna C, Melguizo C, Alvarez PJ, Delgado JR, Irigoyen A, Rojas I, Pérez-Florido J, Torres C, Perales S, Linares A, Aránega A. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Dig Dis Sci 2014;59:2714-20. [PMID: 25069573 DOI: 10.1007/s10620-014-3291-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
28 Sellmann L, Scholtysik R, Kreuz M, Cyrull S, Tiacci E, Stanelle J, Carpinteiro A, Nückel H, Boes T, Gesk S, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R. Gene dosage effects in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010;203:149-60. [PMID: 21156227 DOI: 10.1016/j.cancergencyto.2010.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
29 Malhotra A, Wang Y, Waters J, Chen K, Meric-Bernstam F, Hall IM, Navin NE. Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulations. Genome Med 2015;7:6. [PMID: 25729435 DOI: 10.1186/s13073-015-0127-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A. Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J Immunol 2012;188:6071-83. [PMID: 22593611 DOI: 10.4049/jimmunol.1102066] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
31 Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N. CD38 and chronic lymphocytic leukemia: a decade later. Blood 2011;118:3470-8. [PMID: 21765022 DOI: 10.1182/blood-2011-06-275610] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 12.5] [Reference Citation Analysis]
32 Alsolami R, Knight SJ, Schuh A. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia? Per Med 2013;10:361-76. [PMID: 24611071 DOI: 10.2217/pme.13.33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
33 Chun K, Wenger GD, Chaubey A, Dash D, Kanagal-shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genetics 2018;228-229:236-50. [DOI: 10.1016/j.cancergen.2018.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
34 Amin NA, Seymour E, Saiya-Cork K, Parkin B, Shedden K, Malek SN. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia. Clin Cancer Res 2016;22:4525-35. [PMID: 27060156 DOI: 10.1158/1078-0432.CCR-15-3103] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
35 Gardiner A, Parker H, Glide S, Mould S, Robinson H, Tracy I, Stankovic T, Oscier D, Strefford J. A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia. Leukemia Research 2012;36:307-10. [DOI: 10.1016/j.leukres.2011.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
36 Del Giudice I, Marinelli M, Wang J, Bonina S, Messina M, Chiaretti S, Ilari C, Cafforio L, Raponi S, Mauro FR, Di Maio V, De Propris MS, Nanni M, Ciardullo C, Rossi D, Gaidano G, Guarini A, Rabadan R, Foà R. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments. Br J Haematol 2016;172:371-83. [PMID: 26597680 DOI: 10.1111/bjh.13859] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
37 Sutton LA, Rosenquist R. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression. Expert Rev Hematol 2015;8:71-8. [PMID: 25345442 DOI: 10.1586/17474086.2015.972930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
38 McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, Krause V, Kumar RA, Grozeva D, Malhotra D, Walsh T, Zackai EH, Kaplan P, Ganesh J, Krantz ID, Spinner NB, Roccanova P, Bhandari A, Pavon K, Lakshmi B, Leotta A, Kendall J, Lee YH, Vacic V, Gary S, Iakoucheva LM, Crow TJ, Christian SL, Lieberman JA, Stroup TS, Lehtimäki T, Puura K, Haldeman-Englert C, Pearl J, Goodell M, Willour VL, Derosse P, Steele J, Kassem L, Wolff J, Chitkara N, McMahon FJ, Malhotra AK, Potash JB, Schulze TG, Nöthen MM, Cichon S, Rietschel M, Leibenluft E, Kustanovich V, Lajonchere CM, Sutcliffe JS, Skuse D, Gill M, Gallagher L, Mendell NR, Craddock N, Owen MJ, O'Donovan MC, Shaikh TH, Susser E, Delisi LE, Sullivan PF, Deutsch CK, Rapoport J, Levy DL, King MC, Sebat J; Wellcome Trust Case Control Consortium. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009;41:1223-7. [PMID: 19855392 DOI: 10.1038/ng.474] [Cited by in Crossref: 495] [Cited by in F6Publishing: 467] [Article Influence: 38.1] [Reference Citation Analysis]
39 Zhao X, Wu Q, Fu X, Yu B, Shao Y, Yang H, Guan M, Huang X, Zhang W, Wan J. Examination of copy number variations of CHST9 in multiple types of hematologic malignancies. Cancer Genet Cytogenet 2010;203:176-9. [PMID: 21156230 DOI: 10.1016/j.cancergencyto.2010.07.132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
40 Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br J Haematol 2010;151:336-45. [PMID: 20812997 DOI: 10.1111/j.1365-2141.2010.08341.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
41 Fang Z, Xiong Y, Zhang C, Li J, Liu L, Li M, Zhang W, Wan J. Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population. Oncol Lett 2010;1:925-30. [PMID: 22966406 DOI: 10.3892/ol_00000163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
42 Fabris S, Scarciolla O, Morabito F, Cifarelli RA, Dininno C, Cutrona G, Matis S, Recchia AG, Gentile M, Ciceri G, Ferrarini M, Ciancio A, Mannarella C, Neri A, Fragasso A. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. Genes Chromosomes Cancer 2011;50:726-34. [PMID: 21638517 DOI: 10.1002/gcc.20894] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
43 Konen JM, Fradette JJ, Gibbons DL. The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors. Cells 2019;9:E52. [PMID: 31878283 DOI: 10.3390/cells9010052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
44 Malek SN. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia. Oncogene 2013;32:2805-17. [PMID: 23001040 DOI: 10.1038/onc.2012.411] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
45 Zhang L, Znoyko I, Costa LJ, Conlin LK, Daber RD, Self SE, Wolff DJ. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genetics 2011;204:654-65. [DOI: 10.1016/j.cancergen.2011.10.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
46 Wan J, Gao Y, Zhao X, Wu Q, Fu X, Shao Y, Yang H, Guan M, Yu B, Zhang W. The association between the copy-number variations of ZMAT4 and hematological malignancy. Hematology 2011;16:20-3. [PMID: 21269563 DOI: 10.1179/102453311X12902908411751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia. Blood 2011;118:3051-61. [PMID: 21795749 DOI: 10.1182/blood-2010-12-327858] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 8.1] [Reference Citation Analysis]
48 Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Montserrat E, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 2010;42:132-6. [PMID: 20062064 DOI: 10.1038/ng.510] [Cited by in Crossref: 179] [Cited by in F6Publishing: 160] [Article Influence: 14.9] [Reference Citation Analysis]
49 Gunnarsson R, Mansouri L, Rosenquist R. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies. Leuk Lymphoma 2013;54:1583-90. [PMID: 23167608 DOI: 10.3109/10428194.2012.751530] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
50 Codony C, Crespo M, Abrisqueta P, Montserrat E, Bosch F. Gene expression profiling in chronic lymphocytic leukaemia. Best Practice & Research Clinical Haematology 2009;22:211-22. [DOI: 10.1016/j.beha.2009.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
51 Yang H, Zhang C, Zhao X, Wu Q, Fu X, Yu B, Shao Y, Guan M, Zhang W, Wan J, Huang X. Analysis of copy number variations of BS69 in multiple types of hematological malignancies. Ann Hematol 2010;89:959-64. [DOI: 10.1007/s00277-010-0966-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
52 Zhang C, Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang W, Wan J. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression. Acta Biochimica et Biophysica Sinica 2010;42:834-8. [DOI: 10.1093/abbs/gmq088] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
53 Lange C, Mittermayr L, Dohm JC, Holtgräwe D, Weisshaar B, Himmelbauer H. High-throughput identification of genetic markers using representational oligonucleotide microarray analysis. Theor Appl Genet 2010;121:549-65. [DOI: 10.1007/s00122-010-1329-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
54 Montserrat E, Moreno C. Genetic lesions in chronic lymphocytic leukemia: clinical implications: . Current Opinion in Oncology 2009;21:609-14. [DOI: 10.1097/cco.0b013e328331b702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 2011;3:31. [PMID: 21631906 DOI: 10.1186/gm247] [Cited by in Crossref: 140] [Cited by in F6Publishing: 123] [Article Influence: 12.7] [Reference Citation Analysis]
56 Ott CJ, Federation AJ, Schwartz LS, Kasar S, Klitgaard JL, Lenci R, Li Q, Lawlor M, Fernandes SM, Souza A, Polaski D, Gadi D, Freedman ML, Brown JR, Bradner JE. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell 2018;34:982-995.e7. [PMID: 30503705 DOI: 10.1016/j.ccell.2018.11.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 11.5] [Reference Citation Analysis]
57 Yachida S, Iacobuzio-Donahue CA. Evolution and dynamics of pancreatic cancer progression. Oncogene 2013;32:5253-60. [PMID: 23416985 DOI: 10.1038/onc.2013.29] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
58 Rigolin GM, Saccenti E, Rizzotto L, Ferracin M, Martinelli S, Formigaro L, Cibien F, Cavallari M, Lista E, Daghia G, Sofritti O, Ciccone M, Cavazzini F, Lupini L, Bassi C, Zagatti B, Negrini M, Cuneo A. Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. Oncotarget 2014;5:140-9. [PMID: 24334759 DOI: 10.18632/oncotarget.1382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
59 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Gunnarsson R, Mansouri L, Isaksson A, Göransson H, Cahill N, Jansson M, Rasmussen M, Lundin J, Norin S, Buhl AM, Smedby KE, Hjalgrim H, Karlsson K, Jurlander J, Geisler C, Juliusson G, Rosenquist R. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica 2011;96:1161-9. [PMID: 21546498 DOI: 10.3324/haematol.2010.039768] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
61 Gunnarsson R, Isaksson A, Mansouri M, Göransson H, Jansson M, Cahill N, Rasmussen M, Staaf J, Lundin J, Norin S, Buhl AM, Smedby KE, Hjalgrim H, Karlsson K, Jurlander J, Juliusson G, Rosenquist R. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients. Leukemia 2010;24:211-5. [DOI: 10.1038/leu.2009.187] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
62 Zhang J, Gao Y, Zhao X, Guan M, Zhang W, Wan J, Yu B. Investigation of copy-number variations of C8orf4 in hematological malignancies. Med Oncol 2011;28 Suppl 1:S647-52. [PMID: 20878554 DOI: 10.1007/s12032-010-9698-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
63 Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K, Malek SN. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res 2011;17:6778-90. [PMID: 21890456 DOI: 10.1158/1078-0432.CCR-11-0785] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
64 Best G, Thompson P, Tam CS. Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia. Leuk Lymphoma 2012;53:2105-15. [PMID: 22568511 DOI: 10.3109/10428194.2012.692088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Rodríguez D, Bretones G, Arango JR, Valdespino V, Campo E, Quesada V, López-Otín C. Molecular pathogenesis of CLL and its evolution. Int J Hematol 2015;101:219-28. [PMID: 25630433 DOI: 10.1007/s12185-015-1733-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
66 Peiró AM, Tang CM, Murray F, Zhang L, Brown LM, Chou D, Rassenti L, Kipps TJ, Insel PA. Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease. J Hum Genet 2011;56:676-81. [PMID: 21796143 DOI: 10.1038/jhg.2011.80] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Guan M, Liu L, Zhao X, Wu Q, Yu B, Shao Y, Yang H, Fu X, Wan J, Zhang W. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies. Clin Lymphoma Myeloma Leuk 2011;11:50-3. [PMID: 21454190 DOI: 10.3816/CLML.2011.n.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
68 Forsberg LA, Absher D, Dumanski JP. Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. J Med Genet 2013;50:1-10. [PMID: 23172682 DOI: 10.1136/jmedgenet-2012-101322] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
69 Travella A, Ripollés L, Aventin A, Rodríguez A, Bezares RF, Caballín MR, Slavutsky I. Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis. Hematol Oncol 2013;31:79-87. [PMID: 22961973 DOI: 10.1002/hon.2025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
70 Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, Riggs M, Eberling Y, Troge J, Grubor V. Inferring tumor progression from genomic heterogeneity. Genome Res. 2010;20:68-80. [PMID: 19903760 DOI: 10.1101/gr.099622.109] [Cited by in Crossref: 354] [Cited by in F6Publishing: 303] [Article Influence: 27.2] [Reference Citation Analysis]
71 Zent CS, Van Dyke DL. Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications. Leuk Lymphoma 2010;51:186-7. [PMID: 20109070 DOI: 10.3109/10428190903580436] [Reference Citation Analysis]
72 Chu F, Feng Q, Qian Y, Zhang C, Fang Z, Shen G. ERBB2 gene amplification in oral squamous cell malignancies: a correlation with tumor progression and gene expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:90-5. [PMID: 21531597 DOI: 10.1016/j.tripleo.2011.01.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
73 Forsberg LA, Absher D, Dumanski JP. Republished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime. Postgrad Med J 2013;89:417-26. [PMID: 23781115 DOI: 10.1136/postgradmedj-2012-101322rep] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
74 Calissano C, Damle RN, Hayes G, Murphy EJ, Hellerstein MK, Moreno C, Sison C, Kaufman MS, Kolitz JE, Allen SL, Rai KR, Chiorazzi N. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia. Blood 2009;114:4832-42. [PMID: 19789386 DOI: 10.1182/blood-2009-05-219634] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 8.1] [Reference Citation Analysis]
75 Regulski M, Lu Z, Kendall J, Donoghue MT, Reinders J, Llaca V, Deschamps S, Smith A, Levy D, McCombie WR, Tingey S, Rafalski A, Hicks J, Ware D, Martienssen RA. The maize methylome influences mRNA splice sites and reveals widespread paramutation-like switches guided by small RNA. Genome Res 2013;23:1651-62. [PMID: 23739895 DOI: 10.1101/gr.153510.112] [Cited by in Crossref: 184] [Cited by in F6Publishing: 165] [Article Influence: 20.4] [Reference Citation Analysis]
76 Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leuk Lymphoma 2014;55:920-8. [PMID: 24047479 DOI: 10.3109/10428194.2013.845882] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]